Veloxis Pharmaceuticals A/S Mutual Funds

Health Care & Life Sciences » Biotechnology | Veloxis Pharmaceuticals A/S

Veloxis Pharmaceuticals A/S | Mutual Funds

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

939,419

0.06%

0.3%

08/31/2018

Danske Invest Danmark Indeks Small Cap

939,419

0.06%

0.3%

08/31/2018

Danske Invest Danmark Indeks

636,817

0.04%

0.07%

08/31/2018

RAM (Lux) Systematic Funds - European Equities

28,265

06/30/2017

-315,593

08/31/2018

RAM (Lux) Systematic Funds - Long/Short European Equities

-16,033

06/30/2017

View Profile

Address	Amerika Plads 37 Copenhagen CR 2100 Denmark
Employees	-
Website	http://www.veloxis.com
Updated	07/08/2019
Veloxis Pharmaceuticals A/S is a commercial-stage specialty pharmaceutical company, which engages in the development and commercialization of medicine for the prevention of organ rejection in kidney transplant patients. The company is focused on the direct commercialization of Envarsus XR in the US, expansion of partnerships for markets, and acquisition of assets utilized in transplant patients and by adjacent medical specialties. Veloxis Pharmaceuticals was founded in June 2002 and is headquartered in Copenhagen, Denmark.